Medifast Inc (MED) insider trading
Every open-market stock purchase and sale by Medifast Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $242K over the last 12 months (2 buys).
- Last insider buy: Scott Schlackman (Director), $31.3K, 5 months ago.
Last 12 months: insiders bought $242K (2 buys) and sold $0 (0 sales). Last close $12.10 on Jun 4, 2026.
Recent MED insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 26, 2026 | Jeffrey Matthew Rose (Director) | Bought (not open market) | — |
| May 26, 2026 | Elizabeth A. Geary (Director) | Bought (not open market) | — |
| May 26, 2026 | Parsa Kiai (Director) | Bought (not open market) | — |
| May 26, 2026 | Parsa Kiai (Director) | Bought (not open market) | — |
| May 26, 2026 | Ming Xian (Director) | Bought (not open market) | — |
| May 26, 2026 | Scott Schlackman (Director) | Bought (not open market) | — |
| May 26, 2026 | Andrea B Thomas (Director) | Bought (not open market) | — |
| May 26, 2026 | Jeffrey Matthew Rose (Director) | Bought (not open market) | — |
| May 11, 2026 | Scott Schlackman (Director) | Bought | $31.3K |
| May 8, 2026 | Scott Schlackman (Director) | Bought | $31.6K |
| Mar 25, 2026 | Daniel R Chard (CEO) | Sold (not open market) | $193K |
| Mar 25, 2026 | James P. Maloney (CFO) | Sold (not open market) | $30.9K |
| Mar 25, 2026 | Jonathan Barrett MacKenzie (C-suite exec) | Sold (not open market) | $8.3K |
| Mar 25, 2026 | Daniel R Chard (CEO) | Bought (not open market) | — |
| Mar 25, 2026 | James P. Maloney (CFO) | Bought (not open market) | — |
| Mar 25, 2026 | James P. Maloney (CFO) | Bought (not open market) | — |
| Mar 25, 2026 | Jonathan Barrett MacKenzie (C-suite exec) | Bought (not open market) | — |
| Mar 25, 2026 | Daniel R Chard (CEO) | Bought (not open market) | — |
| Mar 20, 2026 | Daniel R Chard (CEO) | Bought | $179K |
| Mar 17, 2026 | Daniel R Chard (CEO) | Sold (not open market) | $26.5K |
| Mar 17, 2026 | James P. Maloney (CFO) | Sold (not open market) | $4.8K |
| Mar 17, 2026 | Jonathan Barrett MacKenzie (C-suite exec) | Sold (not open market) | $704 |
| Mar 13, 2026 | Daniel R Chard (CEO) | Sold (not open market) | $68.1K |
| Mar 13, 2026 | James P. Maloney (CFO) | Sold (not open market) | $8.8K |
| Mar 13, 2026 | Jonathan Barrett MacKenzie (C-suite exec) | Sold (not open market) | $1.9K |
Who's trading MED
- Scott Schlackman, Director: bought $63K (2 buys), last May 26, 2026
- Elizabeth A. Geary, Director: other filings, last May 26, 2026
- Jeffrey Matthew Rose, Director: other filings, last May 26, 2026
- Ming Xian, Director: other filings, last May 26, 2026
- Andrea B Thomas, Director: other filings, last May 26, 2026
- Parsa Kiai, Director: other filings, last May 26, 2026
- Jonathan Barrett MacKenzie, C-suite exec: other filings, last Mar 25, 2026
- Daniel R Chard, CEO: bought $179K (1 buy), last Mar 25, 2026
- James P. Maloney, CFO: other filings, last Mar 25, 2026
Get free alerts when an insider at Medifast Inc files a new trade →